Elias Sharba, MD
Critical Care Medicine · Dearborn, MINPI 1558331447
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 80.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $3,713 and has fallen 93.3% since, to $249 in 2025. Among critical care medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $89.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- GSK$314
- AstraZeneca$250
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$178
- Regeneron Healthcare Solutions, Inc.$148
- Inspire Medical Systems, Inc.$88
- plus $104 from 5 others
What the payments were for
- Travel & lodging$98518%
- Food & beverage$1,42626%
- Education$3,03956%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $4,368 |
| GSK | 27 | $314 |
| AstraZeneca | 8 | $250 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $178 |
| Regeneron Healthcare Solutions, Inc. | 7 | $148 |
| Inspire Medical Systems, Inc. | 1 | $88 |
| Boehringer Ingelheim | 1 | $27 |
| Verona Pharma, Inc. | 1 | $22 |
| Pulmonx Corporation | 1 | $21 |
| Grifols USA, LLC | 1 | $18 |
| Insmed, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Da Vinci Surgical System$1,121
- TAGRISSO$129
- LifeVest$100
How this compares
$5,450 in reported general payments places this provider in the 90th percentile of 177 critical care medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 155 | $157,785 |
| Breo ElliptaFluticasone/Vilanterol | 75 | $37,121 |
| Spiriva RespimatTiotropium Bromide | 37 | $23,448 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $18,319 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $16,704 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 17 | $10,647 |
| Pulmicort FlexhalerBudesonide | 16 | $7,491 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 43 | $7,385 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 22 | $6,602 |
| Incruse ElliptaUmeclidinium Bromide | 14 | $6,013 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 125 | $4,603 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $4,602 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $2,645 |
| Fluticasone Propionate | 81 | $1,621 |
| Ventolin HfaAlbuterol Sulfate | 23 | $1,257 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $314 | $219,239260 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $27 | $34,09554 claims |
| AstraZenecaBreztri Aerosphere, Pulmicort Flexhaler, Symbicort | $250 | $28,79854 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 177 critical care medicine providers in Michigan.
Other critical care medicine in Dearborn
- Andrew EasowDearborn$10K
- Angel Peralta-AvilaDetroit$147K
- Moumen AsbahiTroy$81K
- Mujahed AbbasLansing$28K
- Abdulrazak AlchakakiSouthfield$19K
- Narayana GandhamSaint Joseph$18K
- Sara MirzaAnn Arbor$12K
- Asker AsmiRiverview$11K
- Jeffery WiltGrand Rapids$10K
- Furqan SiddiqiSaint Joseph$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.